These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 5816435)

  • 1. [Simultaneous increase of drug effect on the heart and tolerance of digoxin by combination of electrolytes, flavones and purines].
    Jaursch U; Lander E; Schmidt R; Schmoldt H; Simon KH
    Med Welt; 1969 Jul; 27():1547-52. PubMed ID: 5816435
    [No Abstract]   [Full Text] [Related]  

  • 2. [Personal experiences with coroverlan digoxin in the therapy of cardiac insufficiency].
    Grujić M; Perinović M
    Med Arh; 1969; 23(5):61-7. PubMed ID: 5201556
    [No Abstract]   [Full Text] [Related]  

  • 3. [On the treatment of the aging heart. Experiences with Coroverlan in so-called "geriatric cures" of the German Red Cross].
    Schäfer G
    Med Welt; 1966 Jun; 25():1386-92. PubMed ID: 6010753
    [No Abstract]   [Full Text] [Related]  

  • 4. [Double blind test for objective evaluation of the therapeutic effect of Coroverlan].
    Dreyer H; Schmidt R; Burrey U; Griesser G; Helbig J
    Med Welt; 1967 Sep; 35():2039-44. PubMed ID: 4876032
    [No Abstract]   [Full Text] [Related]  

  • 5. [Contribution to the problem of digitalis therapy of the heart in the aged. (Experiences of a reconvalescent home for aged people)].
    Schäfer G
    Dtsch Med J; 1968 Mar; 19(5):165-70. PubMed ID: 5718168
    [No Abstract]   [Full Text] [Related]  

  • 6. A comparison between the effects of diltiazem and isosorbide dinitrate on digoxin pharmacodynamics and kinetics in the treatment of patients with chronic ischemic heart failure.
    Mahgoub AA; El-Medany AH; Abdulatif AS
    Saudi Med J; 2002 Jun; 23(6):725-31. PubMed ID: 12070557
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Clinical study on the subtoxic full effective and maintenance dose of digoxin under the influence of spironolactone. Studies on the decompensated heart patient].
    Krämer KD; Ghabussi P; Hochrein H
    Arzneimittelforschung; 1973 Apr; 23(4):508-11. PubMed ID: 4740227
    [No Abstract]   [Full Text] [Related]  

  • 8. [Digacin].
    Internist Prax; 1965; 5(3):487-8. PubMed ID: 5830702
    [No Abstract]   [Full Text] [Related]  

  • 9. Acute magnesium administration and frequency of ventricular arrhythmia in heart failure.
    Bradding P; Withers N
    Circulation; 1994 Nov; 90(5):2566. PubMed ID: 7955222
    [No Abstract]   [Full Text] [Related]  

  • 10. [ECG studies of the resorption quota of the heart affecting glycosides].
    Schellhorn W; Kaltenbach M
    Med Klin; 1969 May; 64(18):832-6. PubMed ID: 5814962
    [No Abstract]   [Full Text] [Related]  

  • 11. [Treatment of chronic heart failure with digitalis: are there still indications?].
    Strasser RH
    Dtsch Med Wochenschr; 1999 Sep; 124 Suppl 2():S32-6. PubMed ID: 10535044
    [No Abstract]   [Full Text] [Related]  

  • 12. [Effect of potassium and magnesium salts in acute and chronic coronary insufficiency and its complications].
    Lewandowicz J
    Wiad Lek; 1967 Apr; 20(11):1039-41. PubMed ID: 6075336
    [No Abstract]   [Full Text] [Related]  

  • 13. Potassium and magnesium depletions in congestive heart failure--pathophysiology, consequences and replenishment.
    Iezhitsa IN
    Clin Calcium; 2005 Nov; 15(11):123-33. PubMed ID: 16272623
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Treatment of cerebral circulatory insufficiency in latent cardiac insufficiency].
    Wille T
    Med Welt; 1970 Jan; 2():80-3. PubMed ID: 4392336
    [No Abstract]   [Full Text] [Related]  

  • 15. Digoxin affects potassium homeostasis during exercise in patients with heart failure.
    Schmidt TA; Bundgaard H; Olesen HL; Secher NH; Kjeldsen K
    Cardiovasc Res; 1995 Apr; 29(4):506-11. PubMed ID: 7796444
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical application of inotropic drugs.
    Counihan TB
    Eur Heart J; 1982 Dec; 3 Suppl D():143-7. PubMed ID: 7160398
    [No Abstract]   [Full Text] [Related]  

  • 17. [The significance of the "minor cardiac treatment" for the senile heart].
    Kohler KM
    Med Monatsschr; 1969 Jul; 23(7):322-4. PubMed ID: 5817057
    [No Abstract]   [Full Text] [Related]  

  • 18. [Ambulatory therapy of cardiac insufficiency with special reference to mineral metabolism].
    Kastner H
    Med Welt; 1965 Nov; 46():2609-11. PubMed ID: 5885127
    [No Abstract]   [Full Text] [Related]  

  • 19. [Clinical experiences with Cardiopon, a cardiovascular system stimulating agent].
    Voelker K
    Med Welt; 1968 Jun; 23():1431-4. PubMed ID: 5752728
    [No Abstract]   [Full Text] [Related]  

  • 20. [Clinical experience with the association of proscillaridine and hydroxyethyltheophylline (Teo-Talusin)].
    Rizzo SC
    Minerva Med; 1968 Dec; 59(104):5939-44. PubMed ID: 5752729
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.